Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.New data confirms effectiveness of NovoMix 30 in diabetes
The meta-analysis evaluated the results of nine clinical trials comparing NovoMix 30 with biphasic human insulin in a total of 1,674 type II and 151 type I diabetes
The meta-analysis evaluated the results of nine clinical trials comparing NovoMix 30 with biphasic human insulin in a total of 1,674 type II and 151 type I diabetes
The EMEA submission is based on a study which evaluated Alimta plus cisplatin versus Gemzar (gemcitabine HCl for injection) plus cisplatin. The study met its primary endpoint of
The trial, designed to enroll 40 patients, presently has patients enrolled at seven clinical sites in the US and was closed to further enrollment with the addition of
The Quill Self-Retaining System (SRS) Polydioxanone (PDO) is a longer-lasting absorbable suture, which is typically used for deeper tissue closures. With CE Mark approval to market the additional
CHDI has access to a variety of relevant research tools, including in vitro and in vivo assays and animal models. Intellect is the exclusive licensee of patents related
Peter Hillmen, lead investigator of the pivotal study comparing Campath against chlorambucil said: “Campath is clearly an important single agent for the first-line treatment of chronic lymphocytic leukemia
The poster presentation, at the 29th Annual Meeting of the American Society for Bone and Mineral Research in Honolulu, Hawaii, was entitled “Rapid Site-Specific Bone Growth by a
The double-blinded, randomized, placebo-controlled trial will assess cobiprostone (SPI-8811), safety and efficacy in preventing NSAID-induced gastric and duodenal ulcers, erosions and dyspeptic symptoms in patients with arthritis. Sucampo
Michael Tardugno, president and CEO, said: “The FDA’s request is consistent with the SPA process and does not in any way suggest that approvability of our pivotal study
Ciclopirox nail lacquer is a prescription pharmaceutical product used for the topical treatment of onychomycosis. Taro says the FDA has determined that its ciclopirox nail lacquer is safe